Each month, we screen the Europe-listed stocks under Morningstar's coverage for newly undervalued names.
Over the past month, a total of six stocks dropped into undervalued territory, meaning their Morningstar Ratings changed to 4 or 5 stars over the course of the month. Stocks rated 3 stars are fairly valued according to Morningstar analysts, while those rated 1 or 2 stars are considered overvalued.
Those six newly undervalued European stocks, ordered by market-cap, are:
• Vestas Wind Systems VWS
• Swedish Orphan Biovitrum SOBI
• Nordic Semiconductor NOD
• EDP Renováveis EDPR
• Bouygues EN
• Sainsbury's SBRY
All returns in this article are reported in the stock's base currency and all data is sourced from Morningstar Direct.
Newly Undervalued Stocks as of Oct. 15
The Morningstar Europe Index rose 0.91% over the past month, leaving the overall European stock market slightly undervalued, hovering at a 4% discount to its fair value estimate on a cap-weighted basis.
Of the 256 Europe-listed stocks covered by Morningstar analysts:
• 47% are undervalued, 36% are fairly valued, and 17% are overvalued.
• Six are newly undervalued.
• 13 are newly overvalued.
• Three moved from a 4-star rating to a 5-star rating.
• Seven moved from a 5-star rating to a 4-star rating.
• 10 are no longer undervalued.
Morningstar analysts assign every stock under their coverage a fair value estimate, which is an intrinsic measure of the stock’s worth, and an uncertainty rating, which captures the range of potential outcomes for the stock’s fair value estimate. A higher uncertainty rating equates to a larger range of stock prices that are considered fairly valued.
These two metrics, combined with the current stock price, are used to determine a stock's Morningstar Rating.
Metrics for this Month's Newly Undervalued Stocks
Vestas 0Wind Systems VWS
• Morningstar Rating: 4 stars
• One-Month Return: -22.72%
Specialty industrial machinery firm Vestas Wind Systems is down 20.27% over the past three months and 15.27% over the past year. The stock's price is 30% below its fair value estimate of DKK 180.00, with a high uncertainty rating. The large-growth stock has no economic moat.
Swedish Orphan Biovitrum SOBI
• Morningstar Rating: 4 stars
• One-Month Return: -9.36%
Drug manufacturer Swedish Orphan Biovitrum has climbed 7.01% over the past three months and 34.39% over the past year. The stock is trading at a 14% discount to its fair value estimate of SEK 343.00, with a medium uncertainty rating. Swedish Orphan Biovitrum is a mid-growth company with a narrow economic moat.
Nordic Semiconductor NOD
• Morningstar Rating: 4 stars
• One-Month Return: -26.45%
Semiconductor company Nordic Semiconductor is down 37.51% over the past three months and 17.02% over the past year. The stock's price is 24% below its fair value estimate of NOK 127.00, with a high uncertainty rating. The small-growth stock has a narrow economic moat.
EDP Renováveis EDPR
• Morningstar Rating: 4 stars
• One-Month Return: -12.76%
Renewable energy firm EDP Renováveis has gained 4.55% over the past three months and 0.55% over the past year. The large-growth stock has no economic moat. EDP Renováveis is trading at a 18% discount to its fair value estimate of €17.00, with a medium uncertainty rating.
Bouygues EN
• Morningstar Rating: 4 stars
• One-Month Return: -5.69%
Engineering and construction company Bouygues has dropped 7.15% over the past three months and 2.21% over the past year. The stock is trading at a 15% discount to its fair value estimate of €35.00, with a medium uncertainty rating. Bouygues is a mid-value company with no economic moat.
Sainsbury's SBRY
• Morningstar Rating: 4 stars
• One-Month Return: -4.35%
Grocery store Sainsbury's has gained 6.13% over the past three months and 13.46% over the past year. The mid-value stock has no economic moat. Sainsbury's's fair value estimate rose to GBX 315.00 from GBX 301.00 during the month. It ended the month trading at a 12% discount to its new fair value estimate, with a medium uncertainty rating.
This article was generated with the help of automation and reviewed by Morningstar editors.